Datavault AI announces $10M exclusive license with Scilex for biotech data tokenization; milestones up to $2.55B

Datavault AI Inc.

Non-refundable $10M license fee payable in four equal $2.5M quarterly installments from Dec 31, 2025 through Sep 30, 2026.
Up to $2.55B in aggregate sales milestone payments upon Scilex achieving certain net sales thresholds.
5% royalty on net sales of licensed products; minimum $1M annual royalty after 24 months.
License covers worldwide exclusive rights to tokenize and monetize genomic, DNA, diagnostic, therapeutic, and drug data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.